Pre-Clinical studies identifying molecular pathways of neuroinflammation in Parkinson's disease: a systematic review

M Fathi, K Vakili, S Yaghoobpoor… - Frontiers in Aging …, 2022 - frontiersin.org
Parkinson's disease (PD), the second most common neurodegenerative disorder, is
characterized by neuroinflammation, formation of Lewy bodies, and progressive loss of …

Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair

S Vivekanantham, S Shah, R Dewji… - International Journal …, 2015 - Taylor & Francis
Neuroinflammation in Parkinson's disease [PD] is a process that occurs alongside the loss of
dopaminergic neurons, and is associated with alterations to many cell types, most notably …

Neuroinflammation in Parkinson's disease and its potential as therapeutic target

Q Wang, Y Liu, J Zhou - Translational neurodegeneration, 2015 - Springer
Abstract Parkinson's disease (PD), the second most common age-associated
neurodegenerative disorder, is characterized by the loss of dopaminergic (DA) neurons and …

Parkinson's disease and enhanced inflammatory response

I Stojkovska, BM Wagner… - … biology and medicine, 2015 - journals.sagepub.com
Parkinson's disease (PD) is the first and second most prevalent motor and
neurodegenerative disease, respectively. The clinical symptoms of PD result from a loss of …

Neuroinflammation in Parkinson's Disease: From Gene to Clinic: A Systematic Review

C Castillo-Rangel, G Marin… - International Journal of …, 2023 - mdpi.com
Parkinson's disease is a neurodegenerative disease whose progression and clinical
characteristics have a close bidirectional and multilevel relationship with the process of …

[HTML][HTML] Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy

L Qian, PM Flood, JS Hong - Journal of neural transmission, 2010 - Springer
Parkinson's disease (PD) is a neurodegenerative movement disorder characterized by the
progressive loss of dopaminergic neurons in the substantia nigra and depletion of dopamine …

Inflammatory mechanisms in Parkinson's disease: from pathogenesis to targeted therapies

SYH Lee, NJ Yates, SJ Tye - The Neuroscientist, 2022 - journals.sagepub.com
Inflammation is a critical factor contributing to the progressive neurodegenerative process
observed in Parkinson's disease (PD). Microglia, the immune cells of the central nervous …

Inflammation and Parkinson's disease pathogenesis: mechanisms and therapeutic insight

G Forloni, P La Vitola, M Cerovic, C Balducci - Progress in Molecular …, 2021 - Elsevier
Abstract After Alzheimer's disease, Parkinson's disease is the most frequent
neurodegenerative disorder. Although numerous treatments have been developed to control …

Insights into neuroinflammation in Parkinson's disease: from biomarkers to anti‐inflammatory based therapies

NP Rocha, AS De Miranda… - BioMed research …, 2015 - Wiley Online Library
Parkinson's disease (PD) is the second most common neurodegenerative disorder
worldwide, being characterized by the progressive loss of dopaminergic neurons in the …

Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease

SV More, H Kumar, IS Kim, SY Song… - Mediators of …, 2013 - Wiley Online Library
Neuroinflammation is a host‐defense mechanism associated with restoration of normal
structure and function of the brain and neutralization of an insult. Increasing …